Page last updated: 2024-10-30

beta-lapachone and MELAS

beta-lapachone has been researched along with MELAS in 1 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Research Excerpts

ExcerptRelevanceReference
"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a mitochondrial disease caused by mutations in the mitochondrial genome."3.80β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells. ( Jeong, MH; Kim, JH; Kwak, TH; Park, WJ; Seo, KS, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, MH1
Kim, JH1
Seo, KS1
Kwak, TH1
Park, WJ1

Other Studies

1 other study available for beta-lapachone and MELAS

ArticleYear
β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells.
    Biochemical and biophysical research communications, 2014, 11-21, Volume: 454, Issue:3

    Topics: DNA, Mitochondrial; Energy Metabolism; Gene Expression Regulation; HeLa Cells; Humans; Lactic Acid;

2014